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The specificity of the immune response is known to be a  result of the presence of 
receptors for antigen on the surface of lymphocytes. For B lymphocytes the receptors 
are types of immunoglobulins specially designed to be membrane proteins, principally 
membrane IgM and  membrane IgD (mIgM and  mIgD). 1 From  numerous  studies, 
first  with  rabbit  lymphocytes  (1),  and  later  with  human  (2,  3)  and  mouse  (4-6) 
lymphocytes, it has become clear that many of the supposed consequences of inter- 
action of B lymphocyte receptors with antigen could be induced by the interaction of 
such receptors with anti-receptor antibody.  For the most part, this has involved the 
demonstration that anti-immunoglobulin (Ig) antibodies such as anti-allotype or anti- 
isotype  antibodies  cause  polyclonal  B  cell  proliferation,  usually  demonstrated  by 
uptake  of radiolabeled  thymidine.  Earlier  events  in  B  cell  activation,  including 
increased protein and RNA synthesis and cell enlargement, have also been observed 
as  a  consequence  of  stimulation  with  anti-Ig  antibodies  (7).  Furthermore,  both 
Kishimoto and Ishizaka (8) and Parker et al. (9)  have shown that anti-Ig-stimulated 
B  cells  may  become  antibody-secreting  cells  if soluble  mediators  present  in  the 
supernatant  of spleen cells stimulated with  antigen  or concanavalin A  (Con A)  are 
added to these cultures. 
To  better  understand  this  model  of the  activation  of B  cells  by  antigen,  it  is 
important to determine whether all B cells respond to anti-Ig in each of these ways or 
whether  only  some  subpopulations  are  capable  of each  response.  Indeed,  several 
studies now indicate that not all mouse splenic B ceils proliferate in response to anti- 
Ig antibody. For example, B cells from young mice (3-6 wk old) respond very well to 
lipopolysaccharide (LPS), but only poorly to anti-Ig antibodies, such as anti-/t  (10). 
Similarly, cells with  large amounts of mIgM or small amounts of mIgD give poor 
responses to anti-/t, as assessed by [3H]thymidine uptake (11).  Even more striking is 
the inability of B cells from mice with the xid-determined immune defect to proliferate 
in  response  to  this  stimulus  (10).  These  B  cells  do  proliferate  in  response to  LPS. 
Finally, the activation state of the B cell before removal from the animal has recently 
been shown to have a  significant effect in determining which  activation signals are 
* Supported by a fellowship from the Helen Hay Whitney Foundation. 
1  Abbreviations used in this paper: BDFI, (C57BL/6 × DBA/2)FI; CDFI, (CBA/N × DBA/2N)F~; Con A, 
concanavalin A; DCF~, (DBA/2N × CBA/N)F1; HBSS, Hanks' balanced salt solution; LPS, lipopolysac- 
eharide, mIgM, mIgD, membrane form of IgM or IgD; NP-40, Nonidet P-40; PBS, phosphate-buffered 
saline. 
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required in vitro to stimulate it to proliferate and differentiate into antibody-secreting 
cells (12). These observations indicate that  both the degree of development and  the 
state of activation of a  B  cell may influence  its ability to respond  to anti-st.  In  the 
current studies, we have studied the capacity of resting B cell populations to enter the 
G1 phase of the cell cycle in response to anti-st. In addition, we have directly measured 
the fraction of B  cells that synthesize DNA in response to anti-/1 through  the use of 
the  quantitative  fluorescent  DNA  stain  propidium  iodide and  by  flow  microfluo- 
rimetry. 
In both types of experiments, we used density-gradient centrifugation to separate 
resting and partially activated B cell populations and then cultured the resting B cells 
in the completely defined serum-free medium (Iscove's/F-12 medium) recently devel- 
oped  by D.  E.  Mosier  (13)  from  the original serum-free  formulation of Iscove and 
Melchers  (14).  The  homogenous  size  distribution of these  cells made  it  possible to 
study size enlargement in response to anti-st. We found that virtually all small, dense 
B  cells enlarged during  the first 24  h  of stimulation and  that  this enlargement  was 
detectable within  1 h  of addition of anti-st. In contrast, only ~60% of resting B  cells 
synthesized DNA in response to anti-st. On the basis of these results, we conclude that 
anti-st stimulates all resting B  cells to enter G1, but that only a  fraction of these cells 
continue into S phase. 
Materials and  Methods 
Animals.  (C57BL/6J  ×  DBA/2J)F~ (BDFI) female mice were obtained from The Jackson 
Laboratory, Bar Harbor, ME.  (CBA/N ×  DBA/2N)F1  (CDFI) male mice and  (DBA/2N × 
CBA/N)F~ (DCFa) male mice were obtained from the Division of Research Services, National 
Institutes of Health, Bethesda, MD. Mice were used between 2 and 4 mo of age. 
Reagents.  Affinity-purified goat  anti-/~  antibody  was  prepared  essentially as  previously 
described (6).  The  serum  of goat  759  was  the source of the  anti-#.  LPS  w  (Escherichia  coli 
0111 :B4) prepared by the Westphal technique was obtained from Difco Laboratories, Detroit, 
MI. Fluorescent reagents used for analysis of cell surface markers (monoclonal anti-# antibodies 
Bet 1 and Bet 2 [15], monoclonal anti-8, 10.4.22 [16], monoclonal 14G82, and a fluoresceinated 
mouse anti-rat IgG) were kindly provided by Dr. John Kung, National Institutes of Health. 
Cell Preparation.  Spleen cells were teased out of the spleen into Hanks' balanced salt solution 
(HBSS), washed, resuspended in HBSS containing a monoclonal anti-Thy-1.2 antibody (New 
England Nuclear, Boston, MA) and complement (guinea pig serum;  1:4,  Flow Laboratories, 
Inc., Rockville, MD), and incubated at 37°C  for 45  min to lyse the T  cells. This treatment 
reduced the response of the cells to  Con  A  to  small percentage of that  of untreated  cells. 
Complement was removed by centrifugation and washing. The cells were then layered on top 
of a  step gradient composed of 70, 60, and 50%  Percoll (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc. Piscataway, N  J), respectively. In typical experiments 2.5 ml of each solution 
was layered in a sterile capped culture tube (2057;  Falcon Labware, Div. of Becton, Dickinson, 
and Co., Oxnard, CA). Percoll was made isoosmotic by the addition of 10× phosphate-buffered 
saline (PBS); this solution was considered to be "100% Percoll," as defined by Pharmacia. This 
solution was diluted to 70%, the pH was adjusted to 7.4 with HC1, and the osmotic strength, as 
measured by freezing point depression with an Osmette S  (Precision Systems, Inc., Sudbury, 
MA), was adjusted to be between 0.310 and 0.320 osmolal. The 50 and 60% Pereoll solutions 
were obtained by diluting the 70% Pereoll solution with HBSS (without NaHCO3, adjusted to 
pH  7.2).  Similar results were obtained when  the Percoll was diluted with  PBS, a  condition 
which is closer to being isoosmotic for mouse cells (17). The gradient was chilled on ice for at 
least 15 min and then centrifuged at 2,300 g for 12 min at 5°C. In a Falcon 2057  tube, up to 
~10  s cells could be applied to the gradient without a  decrease in the purity of the separated 
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was diluted at  least  twofold with HBSS, pelleted by centrifugation, and then washed twice 
with HBSS and once with culture medium. 
Cell Culture.  Cells were cultured in the serum-free medium recently described by D.  E. 
Mosier (Iscove's/F-12) (13). This medium is 50% Iscove's modified Dulbecco's medium (Gibco 
Laboratories,  Grand Island Biological  Co.,  Grand Island, NY),  50%  Ham's  F-12  medium 
(Gibco Laboratories) with the following additives: insulin (5 #g/ml; bovine crystalline zinc 
insulin; Gibco Laboratories), human transferrin (5 /tg/ml;  Sigma Chemical Co.,  St.  Louis, 
MO), progesterone (3 ×  10  -8 M; Upjohn Laboratories, Kalamazoo, MI), 2-mercaptoethanol 
(5 ×  10  -s M), gentamycin (50 gg/ml), and trace elements, MnCI2-4H20 (10 ng/titer), (NH4)s- 
MoTO~.4H20  (600  ng/liter), NiSO4.6H20  (70  ng/liter), H2SeO~ (1.9/~g/liter),  NaSiOa-9 
H20 (71 /.tg/liter),  SnC12 (50 ng/liter), NaaVO4-4 H20 (600 ng/liter), and CdSO4 (10.4 gg/ 
liter). For most studies 3 ×  106 cells were  cultured in 1 ml of medium in 16-mm Diam flat- 
bottomed tissue culture wells (3524; Costar, Data Packaging, Cambridge, MA). Similar results 
were obtained at cell densities ranging from 1 ×  10  s to 5 x  l0  s cells/well. Cultured cells were 
stimulated with goat anti-/t antibody (50 gg/ml), or with LPS (50 ~g/ml). Cells were harvested 
by gentle pipeting with a Pasteur pipette and all of the cells in the well were analyzed directly. 
For determining the uptake of [3H]thymidine, cells were cultured at 2 ×  10  b cells/well in flat- 
bottomed microtiter plates (3596; Costar). All cultures were incubated at 37°C in an atmosphere 
containing 5% CO2. When it was desirable to prevent cells from completing the cell cycle and 
going from M phase back to G1 phase, 25 ng/ml colcemid was added to the cultures 24 h after 
anti-g. This dose of colcemid was found not to increase cell death significantly, whereas higher 
concentrations did. 
Electronic  Volume  Analysis.  The  size  distribution of  B  lymphocytes  was  determined  by 
electronic analysis using a Coulter Counter (model ZB 1) and a Coulter Channelyzer L (model 
C-1000; Coulter Electronics, Hialeah, FL). The cells were suspended in PBS and analyzed with 
the following settings: amplification, 1/2, aperture current, 2;  100-ram aperture; lower thresh- 
old, 10; upper theshold, 100. Cell volume was determined by using microspheres from Coulter 
Electronics (Hialeah, FL) for calibration. Generally, 40,000 cells were analyzed per sample and 
plotted with full scale equal to 4,000. 
Flow Cytometric Analysis.  The DNA content of individual cells was measured in a Coulter 
TPS- 1 Cell Sorter. Briefly, cells were centrifuged and stained with 50 gg/ml propidium iodide 
(Calbiochem-Behring Corp., American Hoechst  Corp.,  LaJolla, CA)  in 0.1% sodium citrate 
and 0.1% Nonidet P-40 (NP-40)  detergent (18). The hypotonic solution caused cell lysis, but 
left the nuclei intact, with propidium bound to DNA. Between 50,000 and 100,000 nuclei were 
analyzed for each sample. The amount of fluorescence emitted was proportional to the DNA 
content of individual nuclei. Cell  cycle  analysis was  performed by computer assisted  data 
analysis on the National Institutes of Health PDP-10 (Digital Equipment Corp.,  Marlboro, 
MA) by a planimetric integration method as previously described (19). This staining method 
has been criticized by Traganos et al. (20) because of a potential loss of cells in M  phase.  We 
have found that not to be a problem with the lymphocytes used in these experiments based on 
the same two criteria used by Traganos et al.  (20). That is, colcemid did cause a  significant 
increase in the fraction of cells in G2 +  M that does not occur if the nuclei from ceils blocked 
in M  phase are especially fragile,  and microscopic examination revealed that the nuclei from 
these  cells  do  stay  intact  despite  the  lack  of an  obvious nuclear membrane.  Nuclei with 
metaphase chromosomes were observed in equal proportions before hypotonic lysis and after 
flow cytofluorimetry, indicating that the analysis did not result in the disruption of M  phase 
nuclei. 
Flow microfluorimetric analysis of cell surface fluorescence  was performed by W. Leiserson 
(National Institutes of Health) using an FACS II (B-D FACS Systems,  Mountain View, CA). 
Determination of the amounts of mlgM and of the antigen recognized by the  monoclonal 
antibody  14G8  on  individual cells  was  done  by  using rat  monoclonal antibodies  and  a 
fluorescent-labeled mouse anti-rat IgG. In calculating the fraction of positively stained cells, 
the number of cells stained by the fluoresceinated anti-rat IgG alone was subtracted from the 
number of cells stained by the monoclonal antibody followed  by the fluoresceinated anti-rat 
IgG. The median fluorescence intensity was determined by calculating the median fluorescence 
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to gain 16. The amount of IgD expressed on the cells was determined by staining directly with 
fluoresceinated  monoclonal anti-8 (10.4.22). No correction was made to discount  cells binding 
antibody nonspecifically  in determining the fraction of cells staining positively with this reagent. 
The median fluorescence  intensity for mIgD is not comparable to the intensity for the other 
two antigens, because the staining conditions were quite different. 
Results 
Separation of B Lymphocytes by Density-Gradient Centrifugation.  Splenic B lymphocytes 
are known  to exist  in  several different  states.  One  physical  property in  which  they 
show variability is size. Melchers and his colleagues (12, 21 ) have recently emphasized 
that small, dense B lymphocytes have distinct activation requirements when compared 
with larger, blast-like cells and thus any study of B cell activation would be clearer if 
it employed cell populations initially separated on the basis of size and density. 
Fig.  1 presents a  size analysis of splenic B  lymphocytes. Such  cells consisted  of a 
major population  corresponding in size to small, dense lymphocytes and found in a 
single  peak.  A  substantial  number of larger  cells were also  present.  These  did  not 
clearly resolve into a separate peak. 
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FIG.  1.  Cell  volume distribution of density-fractionated B cells. Spleen cells from BDF1 mice were 
treated with anti-Thy-1.2 and complement and then separated on a Percoll  step gradient. Fractions: 
low density (< 1.062), above 50% Percoll;  intermediate density (1.062-1.074),  50-60% Percoll;  dense 
(1.074-1.086),  60  70%  Percoll.  Cell  volume was determined  by electric  resistance and  calibrated 
with microspheres obtained from Coulter Electronics. 
TABLE  I 
Distribution of B Cells Recovered  from Density-Gradient Centrifugation 
Percent of re- 
Fraction  Density  covered cells 
Low density cells  1.062  16 ±  1%* 
Intermediate density B cells  1.062-1.074  24 ±  2% 
Small, dense B cells  1.074-1.086  60 ±  3% 
The results are the average of 10 experiments with BDF~ female mice. 
* Mean ±  SEM. DEFRANCO,  RAVECHE,  ASOFSKY,  AND  PAUL  1527 
Cells were separated into populations of distinctive density by gradient sedimen- 
tation  using Percoll as  the  density medium.  Percoll has  an  inherently low osmotic 
strength  and  gradient  separations  using  it  are  rapid,  versatile,  reproducible,  and 
inexpensive. Between 50 and 65% of the starting cells were typically recovered from 
the gradient described here. 
Cell populations separated by Percoll density-gradient separation had distinct size 
distributions  as  analyzed  on  a  Coulter  Counter.  The  dense  fraction  from  Percoll 
separation (1.074-1.086 sp gr) was quite homogeneous in size (Fig.  1). Typically, 85- 
90% of these cells were in one sharp peak with a mean volume of 110 #m 3, conforming 
in size to the small cells found in the unseparated population. The cells of intermediate 
density  (typically  -25%  of the  recovered  cells)  had  a  reproducibly  larger  size  as 
measured  electrically (mean  volume,  140  pro3).  A  similar difference between  these 
two cell fractions was also observed by light-scatter analysis (data not  shown).  The 
cells of the lightest density fraction had a  very heterogeneous size profile. The percent 
of cells recovered in each of these density ranges is shown in Table I. 
The representations of mIgM, of mIgD, and of the membrane antigen recognized 
by 14G8 on the fractionated cells were determined by flow microfluorimetry. Results 
from  representative experiments are presented in Table II. The cells applied to the 
Percoll gradient, having been  treated with  anti-Thy-l.2 antibody and complement, 
were  predominantly  B  cells. The  least  dense  fraction  was  somewhat  depleted of B 
cells  in  comparison  to  the  unfractionated  cells.  This  is  in  agreement  with  the 
observations  that  this  fraction  was  markedly enriched  for phagocytic macrophages 
and for antigen-presenting cells (J.  Mond,  D. Longo, and L. Glimcher, unpublished 
observations).  The  B  cells that  were  present  in  this  fraction  had  somewhat  more 
mIgM,  as judged  by median  fluorescence intensity, than  did  the  B  cells of higher 
TABLE II 
Membrane Markers of Cells in Distinct Density Fractions 
Cells* 
mIgM~:  mIgD§  14G8 antigenS: 
Median  Median  Percent  Percent  Percent of  Percent of  Median flu-  fluores-  fluores- 
of cells  cence[[  of cells  cence  cells posi-  B cells¶  orescence[[ 
positive  intensity  positive  intensity  rive  positive  intensity 
Unfractionated  76  520  75  670  41  53  170 
Low density  58  700  82**  490  43  74  430 
Intermediate density  63  500  75**  420  45  71  250 
High density  80  300  85  960  38 (23)~::[:  47 (29):[:~  60 (150):[::[: 
* Cells were obtained from DCFI~ mice. Similar results were obtained with cells from BDFI mice. 
:~ Stained indirectly; the number of cells stained by mouse anti-rat IgG was subtracted  from the number 
of cells stained indirectly to determine the percent positive cells. 
§ Stained by direct means; no correction for nonspecific staining was made. 
I[ Median fluorescence intensity of positive cells. The median  fluorescence channel,  normalized  to the 
same gain (gain  16), is shown. These numbers are directly comparable for mlgM and  14G8 antigen, 
because the same second stain was used. 
¶ Calculated by using the fraction of mIgM-positive cells stained in the same experiment as the number 
of B cells. 
** The frequency of IgD-bearing  B cells in  the low density and intermediate density populations  are 
probably substantially overestimated because of the binding of the directly fluoresceinated anti-lgD to 
the relatively frequent macrophages in these cell populations. 
:1::~  Values in parentheses are the numbers obtained if the extremely dull staining cells (<channel 60 at gain 
16) are not counted as positive. 1528  FREQUENCY  OF  B  LYMPHOCYTES  RESPONDING  TO  ANTI-Ig 
A  + Anti-p`  B  + LPS 
uJ  I.U  I-- 
,~"  90  ~:  180 
0  0 
~o70  ~'--X  --  ~1"  2:  ~-  --  ~ 50  30  10  ~  --~  ~~  Zx  -- 100140  20  60 
[  I  I  I  1 
°1'o  20  3o  4o  5o  %  20  3o  4o 
TIME IN CULTURE (h}  TIME IN CULTURE (h) 
Fro. 2.  Time-course of DNA synthesis by density-fractionated  B ceils stimulated  with anti-p. (A) 
or LPS (B). B cells at 2 ×  105 cells/well in Iscove's/F-12 medium were pulsed with [3tt]thymidine 
for 4 h at various times after the addition ofanti-/t or LPS to dense B cells or to intermediate density 
B cells. 
density. Indeed, cells in the high density B  cell fraction had considerably less mIgM 
than  did the unseparated  cells or either of the less dense populations. On  the other 
hand, these high density cells had approximately twice the amount of mIgD as did B 
cells of the other two fractions. 
These fractionated B cells were even more distinctive with respect to their expession 
of the surface antigen recognized by the monoclonal antibody 14G8. Kung et al. have 
recently shown  that  this  antigen  is expressed only on  a  subset  of B  cells.  2 The  two 
lighter density fractions contained  B  cells of which  two-thirds to three-fourths  were 
positive with  14G8. These cells displayed relatively intense fluorescence, with the least 
dense  B  cells being brighter than  the intermediate density B  cells. In contrast, only 
about one-half of the high density B cells were positive with  14G8, and many of the 
high density cells (~ 15%)  expressed barely detectable amounts of the surface antigen. 
The  median  fluorescence of the brightest  25%  of these cells was  150,  still somewhat 
less than the median fluorescence for the intermediate density cells (250). 
Response of B Cells Separated by Density to LPS and Anti-tL  B  cell fractions separated 
by density were  found  to  respond  distinctively to  anti-/t and  to  the  B  cell mitogen 
LPS. The high density B  cells incorporated very small amounts of [aH]thymidine in 
the first 24 h  after addition of either activator (Fig. 2).  In contrast, the intermediate 
density cells mounted a  vigorous response to LPS at this time. In many experiments, 
a  small  but  detectable  response  to  anti-/.t  was  observed  at  24  h  in  cultures  of 
intermediate  density cells.  Indeed,  the  response of the  intermediate density cells to 
LPS  was  substantial  as  early as  12  h  after  addition of mitogen  (data  not  shown). 
Furthermore, the intermediate density cells responded much more vigorously to LPS 
than to anti-/~, whereas in the dense B cell population the levels of response were more 
similar. In some experiments the anti-# response of dense cells was greater than  the 
LPS response, particularly when cells were cultured at 5 X  10  a per well. The relatively 
late onset of DNA synthesis in the dense cell population suggests that  it was mainly 
composed of B  cells in the resting state. B cells of intermediate density, on the other 
2 Kung, J. T., S. O. Sharrow, A. Ahmed, R. Habberssett, and W, E. Paul,J. hnmunol. In press. DEFRANCO,  RAVECHE,  ASOFSKY, AND  PAUL  1529 
hand,  were  induced  to  enter  S  phase  much  sooner  than  were  the  dense  B  cells, 
suggesting that these B cells were not in the resting state. These cells may represent 
cells that had become partially activated in vivo, or immature B cells that had not yet 
attained the resting stage of B cell differentiation, or a combination of both of these 
types of cells. 
Size Analysis of Resting B  Cells Stimulated with Anti-tt.  The relatively homogeneous 
size of the dense B cells obtained by density-gradient centrifugation meant that the 
size changes accompanying the activation of these cells could be detected by volume 
analysis. Indeed, the Coulter Counter proved to be excellent for detecting size increases 
occurring in the course of B cell activation. B cells could be shown to be larger within 
1 h  after addition  of anti-/1  (Fig.  3).  Furthermore,  because each  cell's volume was 
recorded  as  part  of the  histogram,  it  proved  possible to  analyze the  frequency  of 
resting B cells that enlarged in response to anti-~. As can be seen in Fig. 3, virtually 
all small B cells increased their size upon stimulation with anti-/z. The enlargement of 
the stimulated cells appeared to occur at similar rates for all cells in the population. 
That  is  to  say, the  histograms of the  stimulated  and  the  nonstimulated  cells both 
showed  single  peaks,  although  with  different  mean  volumes.  No evidence  for two 
subpopulations enlarging at different rates could be found. Two distinctive popula- 
tions  would  probably  have  resulted  in  a  bimodal  size  distribution;  this  was  not 
observed in any experiment among the >20 that were analyzed. 
These size enlargements appear to represent activation of the cells from the resting 
Go  state  into  and  through  the  Gx  phase.  This  conclusion  is  supported  by  our 
preliminary results showing an increase in cellular RNA content of all dense B cells 
paralleling the size increase.  Furthermore, the size enlargements correlate very well 
with  the  ability  of these  cells  to  enter  S  phase  rapidly  in  response  to  a  strong 
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Fro.  3.  Cell  volume distribution of dense  B  cells  stimulated  with anti-~.  High  density  B  cells 
prepared by density-gradient fractionation were cultured for various lengths of time in the presence 
of anti-~ and then subjected to cell  volume analysis.  Results of a  typical experiment are shown. 
Ceils cultured without anti-/.t increased slightly in size soon after being put in Iscove's/F-12 medium, 
probably because the medium is hypotonic (0.290  osmolal). Subsequently, cell  volume remained 
constant for at least  24 h. In this experiment anti-/.t was added to the cells at different times before 
analysis, which was carried out on all samples at the same time. As a result, all cells were in culture 
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Fio. 4.  Increase  in size of high density CDF]c~ B cells cultured with anti-g for 24 h. Cells were 
cultured with or without anti-~t for 24 h in Iscove's/F-12  medium containing 0.15 mg/ml bovine 
serum albumin. 
proliferative signal, such as that provided by LPS (A.  L. DeFranco, E.  S.  Raveche, 
and W. E.  Paul, manuscript in preparation). 
These results strongly suggested that all resting B ceils  respond to anti-g similarly 
in the first  24 h of stimulation. Previous results, however, had indicated that there are 
B cell  populations that do not proliferate in response to anti-g. One such population 
is the B cells  from mice with the xid-determined  B cell  defect  (10).  These cells  have 
been postulated to be similar to a  subpopulation of normal B cells  (22).  Because of 
this, we examined the size changes of dense B lymphocytes prepared from CDF] male 
mice,  which  are  hemizygous for  the  xid  gene.  These  cells  do  not  proliferate  to  a 
detectable degree in response to anti-/~. Nonetheless, many of these cells clearly enlarge 
upon  exposure  to  anti-/~.  Coulter  analysis  (Fig.  4)  showed  that  many  of the  B 
lymphocytes from these mice enlarged in a manner comparable to that of B cells from 
phenotypically normal DCF1 male mice. 
Cell Cycle Analysis of B Cells Stimulated with Anti-g.  As described in the Introduction 
and in the previous section, certain B lymphocyte populations proliferate poorly or 
not at all to anti-/~. No direct measurements of the proportion of  normal B lymphocytes 
that  enter  the  cell  cycle as  a  result  of exposure  to  anti-g  have  been  reported.  To 
address  this  issue  it  was necessary to analyze cells  for entrance  into  S phase  at  the 
single-cell  level.  This  was  done  by  culturing  high  density  B  cells  with  anti-g  for 
varying  times,  lysing  the  cells  at  low  ionic  strength,  staining  intact  nuclei  with 
propidium iodide, a fluorescent dye that binds to DNA and gives a fluorescent signal 
proportional to DNA content, and analyzing them by flow microfluorimetry. Typical 
histograms  of cell  number vs.  DNA content  are shown  in  Fig.  5.  These  data  were 
analyzed by computer to obtain  the  fraction of ceils with  a  unit  amount  of DNA 
(cells  in Go phase or GI phase), the fraction of cells  with twice that amount of DNA 
(cells in G2 phase or M  phase), and the fraction of cells with intermediate amounts of 
DNA (ceils in S phase). 
Determination of the fraction of cells  in  S phase or in G2 +  M  phases at  various DEFRANCO,  RAVECHE,  ASOFSKY,  AND  PAUL  1531 
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FIG.  6.  The  fraction  of high density B  cells entering S  phase in  response to  anti-#.  Cells were 
cultured with or without colcemid, which prevented dividing ceils from leaving M  phase. Analysis 
for DNA content, as described in Materials and Methods, was carried out at different times after 
addition of anti-#. These data were processed to determine the fraction of cells in different phases 
of the cell cycle. Cells with the normal amount of DNA are in Go or Gt phases, cells with twice this 
amount of DNA are in G2 or M  phases, and cells with intermediate amounts of DNA are in S phase. 
The fraction of cells that have responded at any given time is equal to the sum of the cells in S, G2, 
and M  phases in the presence of colcemid, which prevented cells from returning to G1 phase. Values 
for S phase and G2 +  M  phases for cells cultured without co[cemid were corrected for the increase 
in cell numbers due to cell division. (A)  BDF1 female, dense B cells. (B) CDFI male, dense B cells• 1532  FREQUENCY OF B LYMPHOCYTES RESPONDING TO ANTI-Ig 
TABLE III 
Fraction of Cells Entering  S Phase in Response to Anti-I~ and to LPS 
Source  B cells fraction 
Percent of cells responding 
No mitogen  With anti-/~  With LPS 
BDF~  High density  8.1 ±  1.1  (9)*  56.4 +  4.3 (7)  28.3  ±  9.9 (3) 
BDF1  Intermediate density  12.0 ±  2.8 (5)  40.5 +  3.7  (4)  33.0  _  4.1  (4) 
DCF~  High density  6.0 (3)  35.5 ±  1.8 (3)  13.7 +  1.2 (3) 
DCF1  Intermediate density  9 (1)  30 (1)  27 (1) 
CDF1  High density  11.0 ±  1.9 (4)  12.0 ±  1.6 (4)  19.5 ±  1.5 (2) 
CDF1  Intermediate density  10.1 ±  2.0 (2)  11.0 ±  1.0 (2)  26 (1) 
* Mean ±  SEM. Number of experiments in parentheses. 
times after addition of anti-# made it clear that the B cells activated to transit through 
the cell cycle did so in a relatively unsynehronized fashion (Fig. 6 A). An analysis of 
the fraction of cells entering S phase from such data would necessarily underestimate 
the true fraction because some cells would have already gone through S, G2, and M 
phases and returned to G1 phase before other cells had entered S phase for the first 
time. To solve this problem, an inhibitor of mitosis (colcemid; 25 ng/ml) was added 
to the cells after 24 h of stimulation, before any had reached M  phase. This prevented 
cells from completing the cell cycle and returning to G1 phase. Thus, the fraction of 
cells entering S phase could be reliably determined simply by measuring the fraction 
of cells with greater than the unit amount of DNA (i.e., the number of cells in S plus 
the number in G2 +  M). 
The  response  to  anti-# of dense  B  cells  from  BDF~  mice  is  shown  in  Fig.  6 A. 
Typically, no cells entered S phase within the first 24 h  after the addition of anti-#. 
By 30-36 h, there was a  large number of cells in S phase, and by ~40 h, these cells 
were  accumulating  in  M  phase,  since  transit  through  that  phase  was  blocked  by 
colcemid. By ~48 h  in culture, all of the cells that would enter S phase had already 
done so. The fraction of cells in S phase was the same with or without colcemid. This 
demonstrates  that  colcemid did  not  perturb  the  cells before the  finish of S  phase. 
Thus, eolcemid appears to be acting by blocking mitosis, as expected. 
In  contrast,  B  cells  from  the  spleen  of CDF1  male  mice  (mice  carrying  an  X 
chromosome with the defective xid allele) responded very poorly to anti-g (Fig. 6 B), 
in agreement with previous results obtained by uptake of [SH]thymidine (10).  Typi- 
cally, the population of CDFa male cells incubated with anti-g contained only 1-2% 
more cells entering S  phase than  did  the cells cultured without  anti-g  (Table III). 
This increase was not statistically significant. 
The average fraction of cells that entered S phase in response to anti-g and to LPS 
in a series of experiments is shown in Table III. A large fraction of the cells prepared 
from  BDF1  mice  responded  to  anti-#.  For  the  high  density  cell  population,  this 
represented ~48% of the cultured cells.  Because B cells comprised ~80-85%  of the 
high  density cell population,  nearly 60% of the B  cells present  were stimulated  to 
enter S  phase.  By contrast, only 20%  of the cells  (25%  of the  B  cells)  in  the high 
density population  entered  S  phase  in  response to  LPS.  The intermediate density 
fraction also responded quite well to anti-p; -28% of all cells responded, or ~45% of 
the B cells.  Approximately one-third of these B cells responded to LPS. The fraction 
of DCF~c~ B  cells responsive to anti-g  and  to  LPS was  lower than  the  fraction of DEFRANCO, RAVECHE, ASOFSKY, AND PAUL  1533 
responsive BDF1 cells, although it was still a substantial proportion. Cells from CDFad 
animals did not show statistically significant responses to anti-/~ but responded to LPS 
to the same extent as did the DCFld cells. 
Discussion 
We have examined the frequency of resting B lymphocytes that respond to anti-/~ 
antibody in serum-free medium. B cells were fractionated on the basis of density to 
obtain populations that were more homogeneous than those normally obtained from 
the spleen. It was found that cells with densities between  1.086  and  1.074  (70% and 
60%  Percoll,  respectively)  are  relatively  uniform  in  size.  Furthermore,  these  cells 
behaved like resting or Go state cells in that a long period of preparation, >24 h, was 
required before they entered S phase upon stimulation with LPS or anti-#. Based on 
the recovery of cells from the density gradient, these cells accounted for 60% of spleen 
cells previously treated with anti-Thy-1 and complement. In addition to these resting 
B cells, B cells of intermediate density were also recovered. This intermediate density 
population contained nonresting cells, as some of them entered S phase within  12 h 
after the addition  of LPS.  These two fractions were also seen to be phenotypically 
different when the cell surface expression of mIgM, mIgD, and the antigen recognized 
by  14G8 were measured. The separation of these two physiologically distinct  popu- 
lations  of B  cells  made  it  possible  to  study  the  activation  properties  of the  cells, 
especially the resting ceils, in more detail. 
Virtually all high density B  cells were observed to enlarge after being incubated 
with  anti-#.  This enlargement  was continuous  and all B  cells seemed to enlarge at 
roughly the same rate.  There was  no  indication  that  there might  be two  different 
subpopulations with different rates of size increase. This enlargement probably reflects 
cell cycle advancement from the resting Go state to G1 phase of the active cell cycle 
and preparation for entering S phase. 
Although apparently all of the dense B cells enlarged upon stimulation with anti- 
/1, only -60% of these cells from BDF~  spleens and  ~38% of these cells from DCF1 
spleens actually continued  into S phase.  Since 80-85%  of the cells in  these cultures 
were B cells, as defined by the presence of membrane IgM or IgD, these results suggest 
that -25% of the BDF1 cells and 45% of the DCF~ cells were B cells that did not enter 
S phase in response to anti-~t. These calculations assume that cell death in culture was 
evenly distributed between responding and nonresponding cells. While probably an 
oversimplification, this  assumption  is supported  by several  lines  of reasoning.  The 
survival of ceils for 2 d  in Iscove's/F-12 medium was not markedly enhanced by the 
presence of anti-~. Thus, responding cells did not appear to be exempt from cell death 
in culture. Furthermore, the cell size distributions indicate that all B cells, both those 
that will enter S phase and those that will not, enlarged at approximately equal rates, 
at least for the first 24 h. Any possible differences in viability would presumably not 
have occurred until after that time, when nonresponding cells became blocked in their 
transit  through  the  cell  cycle.  Finally,  the  fraction  of cells  with  greater  than  the 
diploid content of DNA did not increase between 48 h of culture and 60 h of culture. 
If the nonresponding cells were dying more rapidly, this fraction would have continued 
to increase.  Nevertheless, the assumption we have made is presumably not  entirely 
accurate, so the true fraction of cells that enter S phase is possibly somewhat biased 
in  one  direction  or  the  other.  Even  if the  responding  or  the  nonresponding  cells 1534  FREQUENCY OF B LYMPHOCYTES RESPONDING TO ANTI-Ig 
account  for all  of the  cell  death,  which  is  the  most  extreme possibility,  the  main 
conclusion  of this work would  not  be changed:  that  is,  that  all  B  cells are equally 
stimulated to enlarge, whereas some ceils are stimulated to enter S phase and some 
cells are not. For example, cell death in the first 48 h was generally just over 50%.  If 
only cells  that  would  not  enter  S  phase  died,  then  the  starting  population  would 
represent -25% responding cells and 75% nonresponding cells. Likewise, if only cells 
that would respond died in culture, then the starting population would represent 75% 
responding cells and 25% nonresponding cells. In either case, there would still  be a 
sizable fraction of cells entering S phase and a sizable fraction of cells not entering S 
phase. 
One interpretation of these results is that there are two functionally distinct subsets 
of B cells, one that can enter S phase in response to anti-/~  and one that cannot. The 
second  B  cell  subset  is  clearly affected  by the  presence of anti-/~,  since  these  cells 
enlarge during the first 24 h  and thus may be considered to have entered G1 phase 
from the resting or Go state. These two subpopulations of B cells were not separated 
from one another by density fractionation, although small, resting B cells responded 
to anti-/~ in somewhat greater numbers than did intermediate density B ceils. 
A major fraction of B cells, probably ~60% in BDFx spleen populations, do respond 
to anti-# by proliferation. This is considerably higher than the proportion of B cells 
that respond to LPS. Previous estimates placed that number at 10-33% of the B cells, 
depending on the strain of mice used  (23).  Those results were obtained by limiting- 
dilution analysis in which cultures were scored as positive on the basis of the presence 
of antibody-secreting cells.  In  the  experiments  reported  here,  the  fraction  of cells 
responding  to  LPS  by proliferation  was  measured  and  found  to  be similar to  the 
previously  reported  fractions  responding  by  antibody  secretion.  A  similar  result 
was also obtained by radioautography of ceils incubated with [3H]thymidine (24).  It 
is striking that  the percent  of cells that  enter  S  phase is not  directly related  to the 
amount  of [3H]thymidine  incorporated.  Thus,  LPS causes much  greater uptake of 
[3H]thymidine  by  intermediate  density  cells  than  does  anti-#,  even  though  anti-/1 
causes more of these cells to enter S phase. This difference may be explained by the 
rate at which cells responding to anti-/~  and to LPS progress through S phase and/or 
by the frequency with which cells enter S phase for a second time. 
Despite the finding that only a  fraction of the high density B cells entered S phase 
in response to anti-~, virtually all these cells undergo size enlargement. This suggests 
that a decision point exists in G1 phase and that only some B cells can be stimulated 
by anti-~t  to "choose" to go on to S  phase.  B ceils from mice with  the xid immune 
defect appear to exemplify those that enlarge hut do not enter S phase in response to 
anti-#. We should emphasize that those B cells from normal mice that enlarge but do 
not enter S phase in response to anti-/t are nonetheless capable of synthesizing DNA 
when appropriately stimulated because culturing dense BDF1 B ceils with anti-/x and 
LPS causes virtually all these cells to enter S phase (A.  L. DeFranco, E. S.  Raveche, 
and W. E. Paul, manuscript in preparation). 
It seems likely that some mediator(s)  from T  cells or macrophages, or perhaps the 
direct  action  of histocompatibility-restricted  T  cells  may  act  similarly  to  LPS  in 
inducing  proliferation  in  those  B  cells  that  enlarge  but  do  not  enter  S  phase  in 
response to anti-/~.  Indeed, it seems plausible that these other stimulants may act at 
the  later G1  decision  point  reached  by cells stimulated  by anti-/x.  It  is tempting to DEFRANCO, RAVECHE, ASOFSKY, AND PAUL  1535 
suggest that antigen, like anti-#, stimulates entry into Gx by specific cells and either 
causes them to enter S  phase or renders them sensitive to appropriate mediators or 
direct T  cells signals, which in turn control entry into S phase. 
Summary 
The frequency of murine B lymphocytes that respond to antibodies directed against 
membrane IgM  was  measured.  These anti-#  antibodies  induced  all,  or almost  all, 
resting B ceils to enlarge over the first 24 h of stimulation. This probably represents 
the transition  from the resting state  (Go) to active transit  through  the cell cycle. In 
contrast, only a  fraction of these cells, ~60% for BDFa mice, continued through the 
cell cycle into S phase. This is consistent with previous experiments that had suggested 
there were some types of B cells that  did not  proliferate in response to anti-#.  The 
results presented here demonstrate that many, perhaps all, of these nonresponding B 
ceils, both from normal mice and from mice with the xid defect, actually do respond 
to the presence of anti-# by going through  early parts of the cell cycle. These cells 
appear to become blocked at some point  before the beginning of S  phase,  perhaps 
requiring a  signal from a  T  cell or a  macrophage to continue through the cell cycle. 
Thus,  the role of antigen  may be to prepare all B  cells for proliferation.  Different 
subpopulations of B cells may then require different regulatory signals before actually 
proliferating or before differentiating into antibody-secreting cells. 
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